Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Firms Sanguine About New Congress, Preparing For Biogeneric Action

Executive Summary

Among a number of potential congressional actions that could benefit the generic industry, generic manufacturers appear to be most bullish about the prospects for the establishment of a pathway for follow-on biologics

You may also be interested in...



Mylan Closes Merck KGaA Merger, Looks To Fill Remaining Pipeline Gaps

Following the close of its acquisition of Merck KGaA's generics unit, Mylan is looking to round out its product portfolio with oncology and women's healthcare products

Mylan Closes Merck KGaA Merger, Looks To Fill Remaining Pipeline Gaps

Following the close of its acquisition of Merck KGaA's generics unit, Mylan is looking to round out its product portfolio with oncology and women's healthcare products

Generic Drug Service, Not Pricing, Is Key Performance Factor – Lehman’s Silver

The success of generic companies will be determined more by the breadth and quality of their offerings than product pricing, Lehman Brothers Senior VP-Specialty Pharmaceutical Research Rich Silver told the Generic Pharmaceutical Association

Related Content

UsernamePublicRestriction

Register

PS048049

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel